| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.21 | 1e-11 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-09 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-08 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-08 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |